The Board of Directors resolves matters prescribed by laws, regulations, and the Articles of Incorporation, and stipulates matters for resolution and reporting under the Board of Directors Regulations. The execution of business is carried out by the President and CEO, Directors in charge of business operations, and Operating Officers. The assignment of duties to Directors and other officers is subject to resolution by the Board of Directors, with the specific details of such assignments determined accordingly.
| Title | Name | Attendance (Fiscal Year Ended June 30, 2025) |
|---|---|---|
| President and CEO | Hidetoshi Shibuya | 100% (6/6 meetings) |
| Executive Vice President | Katsumi Mouri | 100% (6/6 meetings) |
| Member of the Board | Yukinobu Nishino1 | - |
| Member of the Board | Kazuhiro Miyamae1 | - |
| Independent Director | Masatoshi Tamai | 100% (6/6 meetings) |
| Independent Director | Noriyuki Kondo | 100% (6/6 meetings) |
| Independent Director | Masako Osuna2 | 75% (3/4 meetings) |
| Audit and Supervisory Board Member (Full-time) | Tsuyoshi Takehashi | 100% (6/6 meetings) |
| Independent Audit and Supervisory Board Member | Tateki Ataka | 100% (6/6 meetings) |
| Independent Audit and Supervisory Board Member | Masatoshi Ohara | 83% (5/6 meetings) |
Notes:
1. Newly appointed at the 77th Ordinary General Meeting of Shareholders held on September 25, 2025.
2. Newly appointed at the 76th Ordinary General Meeting of Shareholders held on September 27, 2024.
Specific matters considered during the fiscal year ended June 30, 2025, included management policies, organizational and personnel structures, approval of financial results, evaluation of internal controls, verification of cross-shareholdings, construction of new plants, and the establishment of overseas offices.
| Title | Name | Reason for Appointment |
|---|---|---|
| President and CEO | Hidetoshi Shibuya | Mr. Hidetoshi Shibuya has served in key roles within the Company, primarily overseeing domestic pharmaceutical system sales and leading overseas subsidiaries, and has contributed to the advancement of the regenerative medicine manufacturing system business. He led the formulation of the Medium-term Management Plan 2027, leveraging his extensive business experience and extensive knowledge of and deep insight into corporate management. Since his appointment as a Director in 2010, he has gained significant experience in crucial positions, serving as Executive Vice President in 2021, and subsequently as President and CEO in the same year. As he is expected to contribute to the further growth and enhancement of the corporate value of the Shibuya Group by utilizing this expertise and experience, the Company has resolved to appoint him as a Director. |
| Executive Vice President | Katsumi Mouri | Mr. Katsumi Mouri has overseen the corporate strategy, marketing, sales, technology, and production departments of the mechatronics system business since 2011, and possesses extensive business experience and extensive knowledge of and deep insight into corporate management. He has gained significant experience in crucial positions, serving as Senior Managing Director in 2011 and as Executive Vice President in 2023. As he is expected to contribute to the further growth and enhancement of the corporate value of the Shibuya Group by utilizing this expertise and experience, the Company has resolved to appoint him as a Director. |
| Member of the Board | Yukinobu Nishino | Mr. Yukinobu Nishino has served in various positions within the Company's design departments and possesses specialized expertise, particularly in bottling systems. He has gained significant experience in crucial positions, serving as a Member of the Board in 2011 and as a Managing Director in 2014. Following the introduction of the executive officer system in 2023, he has served as a Senior Executive Managing Officer. As he is expected to contribute to the further growth and enhancement of the corporate value of the Shibuya Group by utilizing this expertise and experience, the Company has resolved to appoint him as a Member of the Board. |
| Member of the Board | Kazuhiro Miyamae | Mr. Kazuhiro Miyamae has served in various positions within the administrative departments of the Company and its overseas group companies, including accounting and legal affairs, and possesses extensive experience and insight. He has gained significant experience in crucial positions, serving as a Member of the Board in 2019. Following the introduction of the executive officer system in 2023, he has served as an Executive Managing Officer. As he is expected to contribute to the further growth and enhancement of the corporate value of the Shibuya Group by utilizing this expertise and experience, the Company has resolved to appoint him as a Member of the Board. |
| Independent Director | Masatoshi Tamai | Mr. Masatoshi Tamai possesses extensive experience through his work in auditing at a certified public accounting firm and in tax-related services as a certified public tax accountant. Leveraging this experience, the Company expects that, upon assuming office as a Director, he will provide advice, opinions, and oversight regarding the Company's corporate management, thereby contributing to the enhancement of the Company's corporate value. For these reasons, he has been nominated as a candidate for Independent Director. Although he has not been involved in corporate management in the past, the Company has determined that he will be able to appropriately fulfill his duties as an Independent Director for the reasons stated above and has therefore resolved to appoint him as an Independent Director. |
| Independent Director | Noriyuki Kondo | Mr. Noriyuki Kondo possesses extensive experience from his career at a general trading company, including significant time spent working overseas, as well as experience serving as a head of departments and participating in corporate management as an officer. Leveraging this experience, the Company expects that, upon assuming office as a Director, he will provide advice, opinions, and oversight regarding the Company's corporate management, thereby contributing to the enhancement of the Company's corporate value. For these reasons, the Company has resolved to appoint him as an Independent Director. |
| Independent Director | Masako Osuna | Ms. Masako Osuna has been widely active in various fields, having served as a university professor and an outside officer following her many years of service at the Japan External Trade Organization (JETRO). She possesses extensive experience and a high level of expertise centered on the international economy. Although she has not been involved in corporate management in the past other than by serving as an outside officer, the Company expects that, upon assuming office as a Director, she will provide advice, opinions, and oversight regarding the Company's corporate management, thereby contributing to the enhancement of the Company's corporate value, and has therefore resolved to appoint her as an Independent Director. |
| Audit and Supervisory Board Member (Full-time) | Tsuyoshi Takehashi | Mr. Tsuyoshi Takehashi has served in various positions within the administrative departments of the Company and its group companies, including accounting and finance, and possesses extensive experience and insight. As he is expected to fulfill his role as an Audit and Supervisory Board Member by utilizing this expertise and experience, the Company has resolved to appoint him as an Audit and Supervisory Board Member. |
| Independent Audit and Supervisory Board Member | Tateki Ataka | Mr. Tateki Ataka possesses extensive experience gained over many years at financial institutions and broad expertise in finance and related areas. As he is expected to fulfill his role as an Audit and Supervisory Board Member from a professional perspective, the Company has resolved to appoint him as an Independent Audit and Supervisory Board Member. |
| Independent Audit and Supervisory Board Member | Masatoshi Ohara | Mr. Masatoshi Ohara possesses specialized expertise and extensive experience as an attorney at law. The Company has nominated him as a candidate for Independent Audit and Supervisory Board Member, as it expects him to fulfill his role from a professional perspective, leveraging his knowledge and experience. Although he has not been involved in corporate management in the past other than by serving as an outside officer, the Company has determined that he will be able to appropriately fulfill his duties as an Independent Audit and Supervisory Board Member for the reasons stated above, and has therefore resolved to appoint him as an Independent Audit and Supervisory Board Member. |
Audit and Supervisory Board Members perform their duties by exchanging opinions and consulting with the Accounting Auditor as necessary. In addition, Audit and Supervisory Board Members accompany the internal audit department in conducting internal audits and, as necessary, have the staff of the internal audit department assist in the duties of the Audit and Supervisory Board Members. The internal audit department reports the results of these internal audits to the Audit and Supervisory Board Members.
| Title | Name | Attendance (Fiscal Year Ended June 30, 2025) |
|---|---|---|
| Audit and Supervisory Board Member (Full-time) | Tsuyoshi Takehashi | 100% (7/7 meetings) |
| Independent Audit and Supervisory Board Member | Tateki Ataka | 100% (7/7 meetings) |
| Independent Audit and Supervisory Board Member | Masatoshi Ohara | 86% (6/7 meetings) |
The Audit and Supervisory Board received reports on the status of activities from the full-time Audit and Supervisory Board Member, determined audit policies, audit plans, and the division of duties, and evaluated and decided on the reappointment of the Accounting Auditor. In addition to confirming the establishment and operation of internal control systems and deliberating on the draft audit report, the Board held interviews with the Directors in charge regarding specific important matters.
To enhance the transparency, objectivity, and accountability of the Board of Directors regarding the determination of the nomination and compensation of Directors, the Company has established a Nomination Committee and a Compensation Committee as advisory bodies to the Board of Directors, the majority of whose members are Independent Directors.
| Title | Name | Attendance (Fiscal Year Ended June 30, 2025) |
|---|---|---|
| Senior Managing Director | Yukinobu Nishino* | - |
| Independent Director | Masatoshi Tamai | 100% (2/2 meetings) |
| Independent Director | Noriyuki Kondo | 100% (2/2 meetings) |
Note: Newly appointed on September 25, 2025.
Specific matters discussed during the fiscal year ended June 2025 included the selection of director candidates and revisions to directors’ compensation.
The Company appoints Directors to ensure an appropriate balance of knowledge, experience, and abilities. The Company has developed a skills matrix for Directors and Audit and Supervisory Board Members to clarify the overall diversity and governance of the Board of Directors. The policies and procedures for the appointment of Directors are set forth in the Criteria for Appointment of Directors. The Company selects appropriate individuals as Independent Directors and Independent Audit and Supervisory Board Members in accordance with the independence criteria, ensuring a balanced representation of expertise in fields such as law, accounting, corporate management, and academia.
The Company nominates as candidates for Directors individuals who are capable of fully fulfilling their roles and responsibilities in corporate management, taking into account governance requirements and the characteristics of each business division. The procedures for nominating candidates for Directors are as follows: Directors recommend qualified individuals to the Nomination Committee; the Nomination Committee deliberates on their suitability; following approval by the President and CEO, the proposal is submitted to the Board of Directors; the Board resolves to nominate them as candidates; and they are elected at the General Meeting of Shareholders. The Company nominates as candidates for Audit and Supervisory Board Members, with the consent of the Audit and Supervisory Board, individuals who possess extensive experience, a high level of expertise, and appropriate insight. The Company has introduced a system of operating officers under a mandate contract and operating officers under an employment contract as part of its senior management structure, and recommends individuals who are deemed capable of executing the Company’s business fairly and efficiently based on their knowledge and experience. Operating officers under a mandate contract are selected by the Board of Directors, in accordance with internal policies, from among operating officers under an employment contract based on recommendations from Directors or operating officers under a mandate contract and with the approval of the President and CEO. Operating officers under an employment contract are selected in accordance with internal policies based on recommendations from Directors or operating officers under a mandate contract. Operating officers may be dismissed in accordance with internal procedures if they are determined to be unsuitable based on the above policy.
The Company determines independence in accordance with the independence criteria set forth in the Companies Act and by the relevant financial instruments exchanges, as well as its own criteria. The Company’s own independence criteria are disclosed in the "Independence Criteria for Outside Officers" (PDF: 90KB).
Notification of Independent Officers (PDF: 99KB).
The Company conducted a questionnaire survey of Directors and Audit and Supervisory Board Members regarding the effectiveness of the Board of Directors for the fiscal year ended June 30, 2025, covering matters such as the Board’s composition, roles and responsibilities, operation, and deliberations. The Board of Directors analyzed and evaluated the results and confirmed that it functions effectively overall.
When taking office, the Company’s outside officers receive briefings on the Company’s corporate culture, management policies, industry conditions, and its business, financial, and organizational matters. The Company provides its internal officers with opportunities, including internal and external seminars, to acquire knowledge related to business and organization, as well as financial knowledge, and to understand the roles and responsibilities expected of officers, including legal responsibilities. At an annual promotion meeting, which serves as a presentation forum for the Company’s unique management system based on management by objectives (MBO), officers share information on the status of group companies and other departments.
The Company recognizes that the understanding and support of shareholders and investors are essential for achieving sustainable growth and enhancing corporate value over the medium to long term. To provide accurate information fairly to shareholders and investors and engage in constructive dialogue, the Company strives to enhance the disclosure of corporate information for domestic and overseas investors on its website and to operate open General Meetings of Shareholders, while promoting organic collaboration among the Director in charge of the General Administration Division, the Finance & Accounting Division and other relevant departments.
In addition, when it is deemed beneficial for achieving the Company’s sustainable growth and enhancing its corporate value over the medium to long term, the Company endeavors to engage in individual dialogue with shareholders and investors while paying due attention to the fairness of information disclosure and the prevention of insider information leakage, and to sincerely consider their views and provide feedback to the Board of Directors.
With respect to dialogue with shareholders in the previous fiscal year, the Director in charge of finance served as the point of contact and engaged in dialogue with domestic and overseas institutional investors and securities analysts, regardless of their investment style, mainly through online individual meetings and small meetings.
The main topics of these dialogues include financial results and business strategies.
The Company aims to achieve an ROE that exceeds the cost of shareholders’ equity and to enhance its corporate value sustainably over the long term. The Company also aims to enhance its evaluation in the capital markets by implementing growth investments and strengthening shareholder return measures.

Hidetoshi Shibuya

Katsumi Mouri

Yukinobu Nishino

Kazuhiro Miyamae

Masatoshi Tamai

Noriyuki Kondo

Masako Osuna

Tsuyoshi Takehashi

Tateki Ataka

Masatoshi Ohara
| Title | Name | Gender | Corporate Management Management Strategy | Global Experience | Sales & Marketing | Production, Technology & Development | Finance & Accounting | M&A | HR & Governance | Legal & Compliance | Sustainability |
|---|---|---|---|---|---|---|---|---|---|---|---|
| President and CEO | Hidetoshi Shibuya | Male | 〇 | 〇 | 〇 | 〇 | - | 〇 | 〇 | 〇 | - |
| Executive Vice President | Katsumi Mouri | Male | 〇 | - | 〇 | 〇 | - | - | 〇 | 〇 | 〇 |
| Member of the Board | Yukinobu Nishino | Male | 〇 | - | 〇 | 〇 | - | - | 〇 | 〇 | 〇 |
| Member of the Board | Kazuhiro Miyamae | Male | 〇 | 〇 | - | - | 〇 | 〇 | - | 〇 | - |
| Independent Director | Masatoshi Tamai | Male | 〇 | - | - | - | 〇 | - | 〇 | 〇 | - |
| Independent Director | Noriyuki Kondo | Male | 〇 | 〇 | - | - | - | 〇 | 〇 | 〇 | - |
| Independent Director | Masako Osuna | Female | 〇 | 〇 | - | - | - | - | 〇 | 〇 | 〇 |
| Audit and Supervisory Board Member (Full-time) | Tsuyoshi Takehashi | Male | - | - | - | - | 〇 | - | 〇 | 〇 | - |
| Independent Audit and Supervisory Board Member | Tateki Ataka | Male | 〇 | - | - | - | 〇 | - | - | 〇 | - |
| Independent Audit and Supervisory Board Member | Masatoshi Ohara | Male | - | 〇 | - | - | - | 〇 | 〇 | 〇 | 〇 |
Note: The above matrix does not represent the full range of expertise and experience of the individuals listed.